The BioIndustry Association (BIA) is the voice of the innovative life sciences and biotech industry, enabling and connecting the UK ecosystem so that businesses can start, grow and deliver world-changing innovation.

Explore opportunities to influence, connect and save with the BIA.

Influence policymakers

 Influence

policymakers, ensuring your voice is heard on matters that are critical to the success of your organisation

Connect at BIA events

Connect

with the UK ecosystem through industry-leading events, expert committees and overseas missions

Save

Save

money with the BIA Business Solutions purchasing programme, helping your business grow cost-effectively


Biotech and life sciences news and insights

Press Releases

BIA announces its Charity Partnership for 2024 with RNID

BIA is thrilled to announce its charity partnership of the year for 2024 with RNID, the national charity supporting the 12 million people in the UK who are deaf, have hearing loss or tinnitus. 

BIA responds to the Chancellor's Autumn Statement 2023

Life science spin-outs, start-ups and scale-ups are key drivers of the UK’s innovation-based economy and crucial for discovering and developing new medicines to save lives in the NHS. The UK is home to a third of life science startups founded in Europe since 2012 and companies like them are responsible for nearly two-thirds of medicines being developed globally.

bioProcessUK to celebrate biotech’s shining stars 

The BioIndustry Association (BIA) will honour two distinguished individuals for their exceptional contributions to the innovative life sciences and biotech sector.

UK biotech fundraising picks up with best quarterly total since 2021

The UK biotech sector secured a substantial total of £563 million in venture capital and public financing during the three months spanning June to August 2023, data published today by the UK BioIndustry Association (BIA) and Clarivate shows.

 

Member News

Pioneer Group and Innovate UK join forces on the Launch Programme

Pioneer Group, a company combining laboratory development and operation with venture building, is continuing its collaboration with Innovate UK by bringing its venture development ‘Launch Programme’ to the Exploit stage of Innovate UK’s ICURe programme.

RoslinCT to manufacture first-ever US FDA approved CRISPR-based gene therapy CASGEVY™

RoslinCT to manufacture this ground-breaking treatment for patients with Sickle Cell Disease (SCD) in the US and in the UK for SCD and Transfusion-Dependent Beta Thalassemia

BugBiome wins discovery spark life science programme

BugBiome was announced as the winner of the Discovery Spark life science business support programme at the GIANT Health Healthcare Investment Show on 5th December. BugBiome will be awarded a business support package worth over £100,000, including one year of free lab space at Discovery Park and £50,000 investment from Discovery Park Ventures.

ValiRx seals deal to license late-stage cancer therapy

ValiRx Plc, a life science company focusing on cancer therapeutics and women's health, has announced that ValiRx subsidiary, ValiSeek Ltd, has entered into an exclusive option agreement to license VAL401 with Ambrose Healthcare Ltd, a private UK specialist pharmaceutical company.

 

Blogs and spotlights

CEO Update - 11 December 2023

Last week the UK government published the National vision for engineering biology. The Vision defines government’s collective ambition for engineering biology and sets the direction for government investment, policy and regulatory reform for the next decade. The chapter on responsible and trustworthy innovation sets out the principles and direction we will follow as government builds a dialogue with the public and stakeholders about engineering biology.

The UK's genomics sector: Poised for continued growth and impact

Genomics has become an integral part of the UK's healthcare system, revolutionising patient care and driving innovation within both small and medium-sized enterprises (SMEs) and large pharmaceutical companies. Our new report, Genomics nation 2023, highlights the profound impact of genomics on the UK's life sciences sector and public health system.

CEO Update - 4 December 2023

UK Biobank is a British success story that puts us at the heart of a key global technology of this century. Last week, UK Biobank published the world’s largest collection of full human genomes. Set up 20 years ago, the charity UK Biobank recruited half a million altruistic volunteers to create the world’s most comprehensive source of health data.

bioProcessUK 2023: Honouring excellence, unveiling future leaders 

In a symphony of innovation and camaraderie, the 20th anniversary bioProcessUK conference swept through Brighton, creating an unforgettable experience for the life sciences and biotech community.

 

Latest resources

Here's a selection of featured BIA resources. Explore our Resources Hub  

UK biotech financing June – August 2023

UK biotech is on a robust upward trajectory this year, raising a total of £563 million in venture capital and public financings during the three months leading up to September.

 

Join us at the next BIA event!

Static event listing image gala dinner.png

BIA Gala Dinner 2024

The Roundhouse
TechBio X event listing.png

TechBio X - Cambridge

Melbourn Science Park, Cambridge